S

Sanbo Hospital Management Group Ltd
SZSE:301293

Watchlist Manager
Sanbo Hospital Management Group Ltd
SZSE:301293
Watchlist
Price: 44.01 CNY -6% Market Closed
Market Cap: 9.1B CNY
Have any thoughts about
Sanbo Hospital Management Group Ltd?
Write Note

Sanbo Hospital Management Group Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sanbo Hospital Management Group Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Additional Paid In Capital
ÂĄ1.7B
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Additional Paid In Capital
ÂĄ7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Additional Paid In Capital
ÂĄ1.5B
CAGR 3-Years
-12%
CAGR 5-Years
21%
CAGR 10-Years
14%
Hengkang Medical Group Co Ltd
SZSE:002219
Additional Paid In Capital
ÂĄ1.8B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
35%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Additional Paid In Capital
ÂĄ1.1B
CAGR 3-Years
2%
CAGR 5-Years
35%
CAGR 10-Years
35%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Additional Paid In Capital
ÂĄ2.6B
CAGR 3-Years
118%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sanbo Hospital Management Group Ltd
Glance View

Market Cap
9.1B CNY
Industry
Health Care

Sanbo Hospital Management Group Ltd. engages in the provision of neurosurgery medical service. The company is headquartered in Beijing, Beijing and currently employs 1,733 full-time employees. The company went IPO on 2023-05-05. The firm is principally engaged in the operation of neurospecialty hospitals. The firm is also engaged in general hospital operations. The firm's diagnostic and treatment programs include neurosurgery, neurointervention, neurology, neuro-oncology chemotherapy, neuro-oncology radiotherapy, neurocritical care and other diagnostic and treatment programs. The other diagnostic and treatment programs include surgery, internal medicine, obstetrics and gynecology, pediatrics, emergency department, imaging department, laboratory department and others. The firm primarily operates its businesses in the domestic market.

Intrinsic Value
24.48 CNY
Overvaluation 44%
Intrinsic Value
Price
S

See Also

What is Sanbo Hospital Management Group Ltd's Additional Paid In Capital?
Additional Paid In Capital
1.7B CNY

Based on the financial report for Dec 31, 2023, Sanbo Hospital Management Group Ltd's Additional Paid In Capital amounts to 1.7B CNY.

What is Sanbo Hospital Management Group Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
36%

Over the last year, the Additional Paid In Capital growth was 134%. The average annual Additional Paid In Capital growth rates for Sanbo Hospital Management Group Ltd have been 36% over the past three years .

Back to Top